<DOC>
	<DOCNO>NCT00536718</DOCNO>
	<brief_summary>RATIONALE : Gathering information genetic change patient lobular carcinoma situ breast may help doctor learn disease find good method treatment . PURPOSE : This clinical trial study genetics woman lobular carcinoma situ breast .</brief_summary>
	<brief_title>Genetics Women With Lobular Carcinoma Situ Breast</brief_title>
	<detailed_description>OBJECTIVES : Primary - Identify inherited variation predisposes woman develop lobular carcinoma situ ( LCIS ) breast . - Identify frequency variant determine effect tumor risk . - Determine worthwhile would test variant clinical set high risk could identify , counsel , screen . Secondary - Analysis genetic change within LCIS aim identify case LCIS may progress invasive cancer . OUTLINE : Patients control participant undergo blood collection . DNA extract blood sample use genotype select polymorphism , compare allele frequency ( use associate allele disease ) use genome-wide single nucleotide polymorphism ( SNP ) screen . Archival tumor sample ( available ) patient use DNA- , RNA- , protein-based analysis . All participant complete questionnaire family history , brief medical history , provide epidemiological data genetic counselor . Participants identify risk know hereditary predisposition cancer refer clinical genetics service . Individual result study disclosed participant . Peer Reviewed Funded Endorsed Cancer Research UK . PROJECTED ACCRUAL : A total 2,000 participant ( 1,000 patient 1,000 matched control ) accrue study .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Carcinoma , Lobular</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets 1 follow criterion : Current prior diagnosis lobular carcinoma situ ( LCIS ) breast , include follow case : Pure LCIS LCIS subsequent development invasive breast cancer morphological subtype LCIS presenting incidental find together invasive breast cancer morphological subtype Control participant match age ethnicity LCIS patient Not affect LCIS No history ductal carcinoma situ breast No breast cancer No relative ( 2nd degree ) affect breast cancer Male female PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>invasive lobular breast carcinoma predominant situ component</keyword>
	<keyword>invasive lobular breast carcinoma</keyword>
	<keyword>lobular breast carcinoma situ</keyword>
</DOC>